Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | 43,150 | 0 |
| Depreciation Amortization | N/A | N/A | N/A | 4,360 | 0 |
| Other Working Capital | N/A | N/A | N/A | -3,840 | 0 |
| Other Operating Activity | 42,168 | 21,367 | 13,485 | 8,830 | 38,110 |
| Operating Cash Flow | $42,168 | $21,367 | $13,485 | $52,500 | $38,110 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28,434 | -6,832 | -3,860 | -4,290 | -2,690 |
| Purchase Of Investment | -125,204 | -81,219 | -39,317 | N/A | N/A |
| Sale Of Investment | 132,340 | 105,716 | 47,927 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -138,850 | -105,760 |
| Investing Cash Flow | $-21,298 | $17,665 | $4,750 | $-143,140 | $-108,450 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,117 | -823 | -457 | N/A | N/A |
| Common Stock Issued | 15,700 | 12,370 | 9,862 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 125,110 | 121,740 |
| Financing Cash Flow | $14,583 | $11,547 | $9,405 | $125,110 | $121,740 |
| Beginning Cash Position | 61,404 | 61,404 | 61,404 | 26,920 | 26,920 |
| End Cash Position | 96,857 | 111,983 | 89,044 | 61,400 | 78,330 |
| Net Cash Flow | $35,453 | $50,579 | $27,640 | $34,470 | $51,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 42,168 | 21,367 | 13,485 | 52,500 | 38,110 |
| Capital Expenditure | -28,434 | -6,832 | -3,860 | N/A | N/A |
| Free Cash Flow | 13,734 | 14,535 | 9,625 | 52,500 | 38,110 |